Loading insider details...
Beta
Latest Form 4 (Jun 8, 2026): Grant/Award of 41,600 VNDA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 41,600 | n/a |
| May 20, 2026 | Vanda Pharmaceuticals Inc. (VNDA) | Gift | 25,836 | n/a |
| Jun 17, 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 7,000 | $32.1K |
| Jun 9, 2025 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 59,225 | n/a |
| Nov 18, 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 5,000 | $25.9K |
| May 21, 2024 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 20,529 | n/a |
| Aug 11, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 6,500 | $39.3K |
| Jun 12, 2023 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 17,307 | n/a |
| Jun 21, 2022 | Vanda Pharmaceuticals Inc. (VNDA) | Grant/Award | 12,006 | n/a |
| Jun 15, 2022 | Vanda Pharmaceuticals Inc. (VNDA) | Sale | 2,700 | $25.6K |